Le Lézard
Classified in: Health, Science and technology, Sports and recreation
Subject: PDT

Cercacor Introducing Android Version of Ember App


IRVINE, Calif., Dec. 13, 2017 /PRNewswire/ -- Cercacor, makers of Ember® ? the world's first non-invasive hemoglobin tracker for endurance athletes ? announced it has launched an Android version of its Ember app. Now, users of Android-enabled phones and tablets can purchase Ember and download the new, free app to their devices. Through December 21, Cercacor is also offering a 20% discount on both the Android and iOS versions of Ember Sport Premium ? lowering the price from $699 to $560.

"We know there are many Android users who want Ember," stated Cercacor's Founder & CEO Joe Kiani. "We're making this streamlined, Android version of the app available to athletes and trainers now, which offers the most commonly used features of our iOS version."

HOW EMBER WORKS:
Ember enables users to non-invasively measure certain physical parameters generally in less than one minute without drawing blood. A comprehensive tool that aids in training and recovery assessment, Ember is the only consumer device that provides athletes and their trainers such a wide breadth of data, so quickly and with just one non-invasive optical sensor.

Users download the Ember app to their (Android or iOS) smartphone or tablet, which then connects to the Ember device via Bluetooth. Athletes and trainers use the app to view, build a historic record, and segment and track their collective data. Users can instantly share their data with coaches, fellow athletes or friends by email, SMS and social media. Ember is available on Cercacor's website www.cercacor.com and via Amazon.

ANDROID APP'S CURRENT FEATURES:

ABOUT CERCACOR:
Cercacor is an innovator of non-invasive, easy-to-use monitoring technologies. The company helps people access key health indicators ? empowering them to better understand their bodies, enhance their fitness levels and reach their full potential. Cercacor is passionate about finding better ways to help endurance athletes and everyday people achieve the extraordinary. Its technologies are licensed by Masimo Corporation, a publicly traded, global leader in the development and distribution of non-invasive monitoring solutions in the healthcare professional market. (Online press kit: http://press.cercacor.com/).  

Media contact:
Jason Sherman, 312-577-7650, [email protected], SHERMAN communications and marketing, http://www.shermancm.com 

 

SOURCE Cercacor


These press releases may also interest you

at 06:05
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer's disease, macular degeneration, and glaucoma research grant funding?age-related diseases with no cure that affect more than 335 million people worldwide. This year's...

at 06:00
Proposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care Total Purchase Consideration of up to ?275 Million, Consisting of ?190 Million in Cash Upfront and up to ?85 Million in...

at 06:00
Dr. Luz Hernandez, a leading dentist in Tampa, Florida has redefined her practice to focus on facial aesthetics. Facial Aesthetics by Dr. Luz, https://www.drluzh.com/, provides a wide...

at 06:00
West Pharmaceutical Services, Inc. today announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance....

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...



News published on and distributed by: